The Efficacy and Safety of Bimatoprost SR in Patients With Open-angle Glaucoma or Ocular Hypertension
The Efficacy and Safety of Bimatoprost SR in Patients With Open-angle Glaucoma or Ocular Hypertension
This study will evaluate the efficacy and safety of bimatoprost sustained-release (SR) in patients with open-angle glaucoma or ocular hypertension. The study includes a 12-month treatment period with an 8-month extended follow-up.
Inclusion Criteria:
- Diagnosis of either open-angle glaucoma or ocular hypertension in each eye and both eyes require IOP-lowering treatment.
Exclusion Criteria:
San Francisco, California 94143, United States
Louisville, Kentucky 40215, United States
Philadelphia, Pennsylvania 19104, United States
Wenatchee, Washington 98801, United States
Ciudad Autónoma de Buenos Aires, Buenos Aires C1120AAN, Argentina
Ciudad Autónoma de Buenos Aires, Buenos Aires C1181ACH, Argentina
Ciudad Autónoma de BuenosAires, C1015ABO, Argentina
Halifax, Nova Scotia B3H 2Y9, Canada
Shibīn al-Kawm, Cairo Governorate 32111, Egypt
Pisa, Tuscany 56124, Italy
Cheras, Kuala Lumpur 50586, Malaysia
Meselik, Eskişehir 26480, Turkey (Türkiye)
Pendik, Istanbul 34890, Turkey (Türkiye)
Manisa, 45030, Turkey (Türkiye)